You are here: Industry Insights > Synthetic biology

News List

Decoding the Role of Synthetic Biology in Pharmaceuticals Neeta Ratanghayra
October 16, 2024
Recognized for its transformative potential, synthetic biology has emerged as a technology poised to revolutionize various industries, including pharmaceuticals.
Advancements in the field of synthetic biology in 2023 by ChatGPT ChatGPT
October 20, 2023
Synthetic biology is a multidisciplinary field that combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems.
OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology prnasia
July 21, 2021
OriCiro Genomics announced that it has raised ¥800 million in Series B financing led by The University of Tokyo Edge Capital Partners (UTEC) with participation of ITOCHU Technology Ventures (ITV).
Synthetic Biology Startup Allozymes Raises US $5 Million Seed Round to Deliver Sustainable, Scalable Manufacturing of Natural Ingredients prnasia
July 21, 2021
Allozymes, a Singapore-based, synthetic biology startup, announced today that it has raised US $5 million in a seed financing round led by Xora Innovation, the deep science investment arm of Temasek Holdings.
Antheia Announces $73M Series B to Commercialize Synthetic Biology Platform for Essential Medicines prnasia
July 01, 2021
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, announced that it has raised $73M in Series B financing.
SoftBank returns to back synthetic biology firm Zymergen in a $400M series C round fiercebiotech
December 26, 2018
Zymergen has raised over $400 million in a series C funding round, which it says will help double the capacity of its synthetic biology contract manufacturing platform.....
New selective biosensor made using synthetic biology europeanpharmaceuticalreview
July 27, 2018
The presence of salt provides a persistent challenge, as fluctuations in salt concentrations affect the selectivity and sensitivity of biosensors…
Drug-producing bacteria possible with synthetic biology breakthrough worldpharmanews
March 13, 2018
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles, from the University of Warwick and the University of Surrey.
Synthetic Genomics Launches cGMP Synthetic Biology Suite contractpharma
June 05, 2017
Synthetic Genomics, Inc. and Advaxis, Inc. have completed development and deployment of the first cGMP synthetic biology facility for the production of synthetic DNA constructs.